We are live on
!
Find out more
Assenagon Asset Management Portfolio holdings
AUM
$80.2B
1-Year Est. Return
50.56%
This Fund
S&P 500
This Quarter
Est. Return
-2.31%
1 Year Est. Return
+50.56%
3 Year Est. Return
+139.16%
5 Year Est. Return
+175.94%
10 Year Est. Return
–
AUM
$65.9B
AUM Growth
-$6.77B
(-9.3%)
Cap. Flow
-$45M
Cap. Flow
% of AUM
-0.07%
Top 10 Holdings %
Top 10 Hldgs %
38.99%
Holding
1,238
New
95
Increased
438
Reduced
526
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.23B |
| 2 |
Microsoft
MSFT
|
+$1.21B |
| 3 |
Tesla
TSLA
|
+$712M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$704M |
| 5 |
Chevron
CVX
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$612M |
| 2 |
Apple
AAPL
|
+$601M |
| 3 |
Procter & Gamble
PG
|
+$518M |
| 4 |
Texas Instruments
TXN
|
+$490M |
| 5 |
Pinduoduo
PDD
|
+$477M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.83% |
| 2 | Consumer Discretionary | 15.45% |
| 3 | Healthcare | 12.45% |
| 4 | Communication Services | 9.01% |
| 5 | Financials | 6.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Marathon Petroleum
MPC
$102B
| $29.6M | 0.04% |
121,200
-199,299
| -62% | -$40.2M |
|
277
Stoke Therapeutics
STOK
$2.1B
| $29.5M | 0.04% |
907,015
-320,708
| -26% | -$10.5M |
|
278
CALL
Prudential Financial
PRU
$41.5B
| $29.3M | 0.04% |
300,000
-200,000
| -40% | -$20.7M |
|
|
279
PUT
Prudential Financial
PRU
$41.5B
| $29.3M | 0.04% |
300,000
-800,000
| -73% | -$82.9M |
|
280
PUT
MetLife
MET
$61.2B
| $29M | 0.04% |
410,000
-1,870,000
| -82% | -$140M |
|
281
Newmont
NEM
$139B
| $28.8M | 0.04% |
266,343
-284,462
| -52% | -$32.8M |
|
|
BCPC
282
Balchem Corp
BCPC
$5.67B
| $28.2M | 0.04% |
166,441
+68,809
| +70% | +$11.7M |
|
283
Fair Isaac
FICO
$25B
| $28M | 0.04% |
26,245
+1,137
| +5% | +$1.56M |
|
284
United Therapeutics
UTHR
$22.6B
| $28M | 0.04% |
47,183
+22,555
| +92% | +$11.2M |
|
285
JPMorgan Chase
JPM
$942B
| $27.8M | 0.04% |
94,615
-1,308
| -1% | -$397K |
|
286
JFrog
FROG
$12.8B
| $27.6M | 0.04% |
588,890
-954,121
| -62% | -$46.9M |
|
287
Linde
LIN
$224B
| $27.6M | 0.04% |
55,671
+40,901
| +277% | +$19.3M |
|
288
Supernus Pharmaceuticals
SUPN
$2.57B
| $27.4M | 0.04% |
+530,618
| New | +$27M |
|
|
MRSH
289
Marsh
MRSH
$90.7B
| $27.3M | 0.04% |
157,257
-1,362,907
| -90% | -$245M |
|
290
NMI Holdings
NMIH
$3.37B
| $27.3M | 0.04% |
726,555
-281,195
| -28% | -$10.9M |
|
291
Inspire Medical Systems
INSP
$1.76B
| $26.8M | 0.04% |
520,174
+255,175
| +96% | +$17.9M |
|
292
lululemon athletica
LULU
$13.1B
| $26.8M | 0.04% |
175,169
-263,292
| -60% | -$47.2M |
|
293
CDW
CDW
$18.6B
| $26.7M | 0.04% |
+220,491
| New | +$27.9M |
|
294
Pentair
PNR
$9.91B
| $26.6M | 0.04% |
304,840
-424,823
| -58% | -$41.6M |
|
295
Ferguson
FERG
$45.1B
| $26.4M | 0.04% |
112,971
+105,555
| +1,423% | +$25.7M |
|
296
MongoDB
MDB
$35.4B
| $26.1M | 0.04% |
106,807
+20,990
| +24% | +$7.02M |
|
297
Tapestry
TPR
$24.6B
| $26.1M | 0.04% |
185,054
-166,182
| -47% | -$23.6M |
|
298
Occidental Petroleum
OXY
$59.1B
| $25.9M | 0.04% |
399,157
+297,223
| +292% | +$14.9M |
|
299
Oneok
OKE
$59.7B
| $25.9M | 0.04% |
286,784
-447,887
| -61% | -$36.9M |
|
300
Equifax
EFX
$22.4B
| $25.7M | 0.04% |
142,793
+41,454
| +41% | +$8.23M |
|
Similar funds
CBU
Assenagon Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, Assenagon Asset Management held 1,238 positions worth $65.9B, down 9.3% from $72.6B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Assenagon Asset Management's Q1 2026 filing shows 95 new, 438 increased, 526 reduced and 143 closed positions. Its largest new stake was Webster Financial: 1,581,021 shares worth $110M. The largest sale was Costco, an estimated $612M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Assenagon Asset Management's largest Q1 2026 buy was Webster Financial: 1,581,021 shares worth $110M.
- Assenagon Asset Management added most to Eli Lilly in Q1 2026, an estimated $1.23B increase.
- Assenagon Asset Management's biggest Q1 2026 reduction was Costco, cutting an estimated $612M.
- Assenagon Asset Management fully exited Praxis Precision Medicines in Q1 2026, selling an estimated $120M.
- Assenagon Asset Management's ten largest holdings make up 39% of its $65.9B portfolio in Q1 2026.
- Assenagon Asset Management opened 95 new positions and closed 143 in Q1 2026.
- Assenagon Asset Management's portfolio value fell 9.3% quarter-over-quarter to $65.9B.
Based on Assenagon Asset Management's 13F filing for Q1 2026, filed 20 Apr 2026.